GE Healthcare Partners with Biofourmis for Patient Monitoring
GE HealthCare, Biofourmis collaborate to extend patient monitoring outside the hospital with virtual care-at-home solutions
Overview
GE HealthCare, a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and Biofourmis, a company delivers technology-enabled solutions that bring the right care to any person anywhere, have announced a strategic collaboration aimed at enhancing continuity of care by enabling safe, effective, and accessible care in the home to support the patient journey beyond the hospital setting. The collaboration leverages the combined expertise of two market leaders to scale and deliver innovative care-at-home solutions.
Hospital Concerns
- Hospital systems are experiencing increased cost of care due to workforce shortages, constrained bed capacity and increasing readmission rates.
- Care-at-home programs, which typically include a virtual component, have proven to be effective in decreasing the length of stay and readmission rates which can result in the overall cost of care being reduced.
- Additionally, care-at-home programs can also support patient recovery and safety, with a potential reduction in fall risk and hospital acquired infections.
- Patients using remote solutions in their homes are three times more likely to be satisfied with the overall care experience.
Partnership Goal
- The goal of the GE HealthCare-Biofourmis collaboration is to enable more patients to go home earlier, and offer an alternative to facility-based care with the comfort and peace of mind that they are receiving high quality care at home with the intent of driving healthy behaviours in patients by managing them remotely.
- Moreover, insights from Biofourmis' FDA-cleared, AI-guided algorithms can help care teams deliver efficient, personalized care at home.
GE leaders on Biofourmis'
"Biofourmis' demonstrated success with care-at-home solutions will extend GE HealthCare's current inpatient monitoring portfolio to support patient care from the hospital to home,"" said Ashutosh Banerjee, GE HealthCare. ""Combining our companies' demonstrated capabilities will help revolutionize the way we approach the patient care journey as well as help address current challenges faced by health systems including hospital capacity issues and clinical staffing shortages."
Biofourmis Unique Solutions
- Biofourmis offers care-at-home solutions to deliver and enable care both virtually and in person using its digital platform, with FDA-cleared AI-guided algorithms, clinical-grade wearable devices, in-home services orchestration technology, and nursing services.
- The solutions provide numerous dynamic care pathways with questionnaire-branching logic to provide enhanced clinical context for care teams.
- GE HealthCare's FlexAcuity monitoring solutions in combination with GE HealthCare's virtual care solutions like Mural ICU, Command Center and Digital CMU adapt to rapidly changing patient needs in the hospital and are built on a legacy of innovation.
- By offering Biofourmis' virtual care-at-home solutions to customers, GE HealthCare can extend the care continuum beyond the hospital, and care teams can have a longitudinal patient view beyond the hospital setting.
Leader from Biofourmis
Ross Armstrong, general manager of Biofourmis Care, said: ""Our collaboration will enable health systems and hospitals to leverage the power of technology and data in order to shape patient-focused solutions across the care continuum, no matter where the site of care is.""
GE HealthCare will begin distributing Biofourmis solutions to customers in the United States starting Q1 2024.
About Biofourmis
Biofourmis delivers technology-enabled solutions that bring the right care to any person anywhere. Biofourmis' innovative solutions provide people everywhere with connected access to hospital-level services, virtual provider networks for remote care, in-home services, and life-changing clinical trials—all without leaving their homes.
About GE HealthCare
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!